Ertugliflozin (PF 04971729), 100 mg

Ertugliflozin (Pf 04971729) is used across pharmaceutical, biochemical, and research settings. This compound, identified as an SGLT2 inhibitor, has a molecular formula of C18H22F3N4O4S and a molecular weight of 412.4 g/mol. It exists as a white crystalline powder with a purity of 99% and is supplied in a 100 mg pack size as a solid. Ertugliflozin plays a role in the treatment of type 2 diabetes by promoting glucose excretion through the urine, thereby reducing blood sugar levels. Additionally, it exhibits selectivity for SGLT2 over SGLT1, which may contribute to its therapeutic efficacy and reduced side effects compared to other SGLT2 inhibitors.

• CAS Number: 1210344-57-2